Creative Biolabs reveals the development methodologies for bispecifics for specific targeting purposes.The global biopharmaceutical industry is buzzing over the next wave of immunotherapy breakthroughs, and bispecific antibodies (bsAbs) are among them to have a serious moment in ...Learn More

A 2024 study from PubMed highlights that AI-driven antibody design is gaining major traction in both academic and industrial circles. In the race to develop next-generation biologics, artificial intelligence (AI) is today's game changer, not merely a futuristic tool."One Nature ...Learn More

While the headlines swirl, biotech firms are choosing action over alarm, including Creative Biolabs, which is forging ahead with next-generation vaccine solutions that aim to keep science—and the public—on solid ground.While top U.S. health officials push back against vaccine ...Learn More

Oligonucleotide synthesis is at the forefront of biotechnology, driving significant advancements in the development of next-generation therapeutics. These short DNA or RNA sequences are engineered to modulate gene expression, presenting novel solutions for treating a myriad of ...Learn More

In recent years, Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as one of the most promising advancements in the fight against cancer. This revolutionary approach, leveraging the power of the immune system, has shown remarkable success, particularly in blood cancers. ...Learn More